Literature DB >> 31264353

Risk for Cesarean section in women of advanced maternal age under the changed reproductive policy in China: A cohort study in a tertiary hospital in southwestern China.

Min Xie1, Terence T Lao2, Mingyu Du1, Qian Sun1, Zaiqing Qu1, Junnan Ma1, Xinyan Song1, Mingfang Wang1, Dongqiong Xu1, Runmei Ma1,3.   

Abstract

AIM: To describe changed epidemiological features of advanced maternal age (AMA) and to examine the effect of AMA on the risk for Cesarean section (CS) in a Chinese pregnant population.
METHODS: This retrospective single-center cohort study investigated the changes of epidemiological features of AMA parturients with respect to the revised reproductive policy in China in 43 702 singleton deliveries with live birth at ≥28 weeks managed from January 2005 to December 2016. We also evaluated the pregnancy outcomes in different age groups and risk factors of CS with multivariate analysis.
RESULTS: In this 12-year study period, the average maternal age increased from 28.5 to 30.2 years, and the proportion of AMA raised from 6.5% to 17.2%. AMA was significantly associated with increased risk of adverse pregnancy outcomes, and after adjustment for confounding factors, AMA remained a significant independent risk factor for CS. Furthermore, the effect of AMA in nulliparous women on the risk of CS was more significant than in multiparous women, while the history of previous CS (adjusted odds ratio 39.85) and interdelivery interval ≥10 years (adjusted odds ratio 1.52) also increased the risk of CS in multiparous women.
CONCLUSION: AMA increased the risk of a number of adverse pregnancy outcomes, and was independently associated with increased risk for CS. The increasing number of AMA parturients with risk factors is likely to increase CS rate in China in the near future, thus it is imperative to reduce the rate of primary CS as a matter of policy.
© 2019 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  Cesarean section; China; advanced maternal age; pregnancy outcome; reproductive policy

Mesh:

Year:  2019        PMID: 31264353     DOI: 10.1111/jog.14048

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  6 in total

1.  The assessment of combined karyotype analysis and chromosomal microarray in pregnant women of advanced maternal age: a multicenter study.

Authors:  Ye Shi; Jun Ma; Ying Xue; Jing Wang; Bin Yu; Ting Wang
Journal:  Ann Transl Med       Date:  2019-07

2.  Changes in caesarean section rates in China during the period of transition from the one-child to two-child policy era: cross-sectional National Household Health Services Surveys.

Authors:  Qian Long; Yaoguang Zhang; Jing Zhang; Xiaojun Tang; Carol Kingdon
Journal:  BMJ Open       Date:  2022-04-13       Impact factor: 3.006

3.  Trends in cesarean delivery rates in primipara and the associated factors.

Authors:  Guoqiang Sun; Ying Lin; Honglian Lu; Wenjing He; Ruyan Li; Lijun Yang; Xian Liu; Hongyan Wang; Xuewen Yang; Yao Cheng
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-23       Impact factor: 3.007

4.  The effects of gestational diabetes mellitus with maternal age between 35 and 40 years on the metabolite profiles of plasma and urine.

Authors:  Xiao-Ling He; Xiao-Jing Hu; Bai-Yu Luo; Yin-Yin Xia; Ting Zhang; Richard Saffery; Jamie De Seymour; Zhen Zou; Ge Xu; Xue Zhao; Hong-Bo Qi; Ting-Li Han; Hua Zhang; Philip N Baker
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-02       Impact factor: 3.007

5.  Impact of maternal age on neonatal outcomes among very preterm infants admitted to Chinese neonatal intensive care units: a multi-center cohort study.

Authors:  Zhiye Qi; Yanchen Wang; Guang Lin; Haiyan Ma; Yaojin Li; Weiquan Zhang; Siyuan Jiang; Xinyue Gu; Yun Cao; Wenhao Zhou; Shoo K Lee; Kun Liang; Liling Qian
Journal:  Transl Pediatr       Date:  2022-07

Review 6.  Differences in epidemiology of patients with preeclampsia between China and the US (Review).

Authors:  Ping Shi; Lei Zhao; Sha Yu; Jun Zhou; Jing Li; Ning Zhang; Baoxiang Xing; Xuena Cui; Shengmei Yang
Journal:  Exp Ther Med       Date:  2021-07-15       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.